Are you really an insomniac
or do you think you are?
Up until now, it has not been possible to determine,
in the home setting, how badly someone sleeps. Oxford
BioSignals Ltd, Oxford UK, announces that for the
first time sleep quality can now be assessed objectively
in insomniacs.
Oxford BioSignals Ltd has developed a new product,
BioSomnia, the size of a Walkman, which only requires
a pair of stick-on electrodes to be applied just
before bedtime. At the end of the night, BioSomnia
produces a comprehensive set of statistics on the
brain’s sleep states during the night. These
are then used to quantify the extent of insomnia
or other sleep disorder.
A recent study carried out at the University of
Glasgow and presented at the Associated Professional
Sleep Society meeting in Chicago, June ’03
shows, for the first time, that the common complaint
by insomniacs that they find it difficult to initiate
sleep is confirmed by BioSomnia analysis. Interestingly,
the current technique for monitoring sleep in the
home, the measurement of wrist movements using a
wristwatch (actigraphy), does not show the same correlation.
The objective information provided by BioSomnia
can be used to guide treatment regimes and to show
treatment effects in subjects undertaking behavioural
therapy for their sleep complaint.
For further information contact Emma.Braithwaite@oxford-biosignals.com or Lionel.Tarassenko@oxford-biosignals.com |